Literature DB >> 30044983

Conservation of Structure and Immune Antagonist Functions of Filoviral VP35 Homologs Present in Microbat Genomes.

Megan R Edwards1, Hejun Liu2, Reed S Shabman3, Garrett M Ginell4, Priya Luthra1, Parmeshwaran Ramanan2, Lisa J Keefe5, Bernd Köllner6, Gaya K Amarasinghe2, Derek J Taylor7, Daisy W Leung8, Christopher F Basler9.   

Abstract

Non-retroviral integrated RNA viral sequences (NIRVs) potentially encoding ∼280 amino acid homologs to filovirus VP35 proteins are present across the Myotis genus of bats. These are estimated to have been maintained for ∼18 million years, indicating their co-option. To address the reasons for co-option, 16 Myotis VP35s were characterized in comparison to VP35s from the extant filoviruses Ebola virus and Marburg virus, in which VP35s play critical roles in immune evasion and RNA synthesis. The Myotis VP35s demonstrated a conserved suppression of innate immune signaling, albeit with reduced potency, in either human or Myotis cells. Their attenuation reflects a lack of dsRNA binding that in the filoviral VP35s correlates with potent suppression of interferon responses. Despite divergent function, evolution has preserved in Myotis the structure of the filoviral VP35s, indicating that this structure is critical for co-opted function, possibly as a regulator of innate immune signaling.
Copyright © 2018 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ebola virus; Marburg virus; Myotis bats; VP35; evolution; filovirus; non-retroviral integrated RNA viral sequence

Mesh:

Substances:

Year:  2018        PMID: 30044983      PMCID: PMC6474348          DOI: 10.1016/j.celrep.2018.06.045

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  72 in total

1.  PACT, a double-stranded RNA binding protein acts as a positive regulator for type I interferon gene induced by Newcastle disease virus.

Authors:  T Iwamura; M Yoneyama; N Koizumi; Y Okabe; H Namiki; C E Samuel; T Fujita
Journal:  Biochem Biophys Res Commun       Date:  2001-03-30       Impact factor: 3.575

2.  Molecular phylogenetic reconstructions identify East Asia as the cradle for the evolution of the cosmopolitan genus Myotis (Mammalia, Chiroptera).

Authors:  Manuel Ruedi; Benoît Stadelmann; Yann Gager; Emmanuel J P Douzery; Charles M Francis; Liang-Kong Lin; Antonio Guillén-Servent; Alice Cibois
Journal:  Mol Phylogenet Evol       Date:  2013-08-27       Impact factor: 4.286

3.  Ebolavirus proteins suppress the effects of small interfering RNA by direct interaction with the mammalian RNA interference pathway.

Authors:  Giulia Fabozzi; Christopher S Nabel; Michael A Dolan; Nancy J Sullivan
Journal:  J Virol       Date:  2011-01-12       Impact factor: 5.103

4.  The Marburg virus VP24 protein interacts with Keap1 to activate the cytoprotective antioxidant response pathway.

Authors:  Megan R Edwards; Britney Johnson; Chad E Mire; Wei Xu; Reed S Shabman; Lauren N Speller; Daisy W Leung; Thomas W Geisbert; Gaya K Amarasinghe; Christopher F Basler
Journal:  Cell Rep       Date:  2014-03-13       Impact factor: 9.423

5.  Fruit bats as reservoirs of Ebola virus.

Authors:  Eric M Leroy; Brice Kumulungui; Xavier Pourrut; Pierre Rouquet; Alexandre Hassanin; Philippe Yaba; André Délicat; Janusz T Paweska; Jean-Paul Gonzalez; Robert Swanepoel
Journal:  Nature       Date:  2005-12-01       Impact factor: 49.962

6.  The L-VP35 and L-L interaction domains reside in the amino terminus of the Ebola virus L protein and are potential targets for antivirals.

Authors:  Martina Trunschke; Dominik Conrad; Sven Enterlein; Judith Olejnik; Kristina Brauburger; Elke Mühlberger
Journal:  Virology       Date:  2013-04-11       Impact factor: 3.616

7.  The evolution of novel fungal genes from non-retroviral RNA viruses.

Authors:  Derek J Taylor; Jeremy Bruenn
Journal:  BMC Biol       Date:  2009-12-18       Impact factor: 7.431

8.  Unexpected inheritance: multiple integrations of ancient bornavirus and ebolavirus/marburgvirus sequences in vertebrate genomes.

Authors:  Vladimir A Belyi; Arnold J Levine; Anna Marie Skalka
Journal:  PLoS Pathog       Date:  2010-07-29       Impact factor: 6.823

9.  Inhibition of IRF-3 activation by VP35 is critical for the high level of virulence of ebola virus.

Authors:  Amy L Hartman; Brian H Bird; Jonathan S Towner; Zoi-Anna Antoniadou; Sherif R Zaki; Stuart T Nichol
Journal:  J Virol       Date:  2008-01-16       Impact factor: 5.103

10.  The Ebola Interferon Inhibiting Domains Attenuate and Dysregulate Cell-Mediated Immune Responses.

Authors:  Ndongala Michel Lubaki; Patrick Younan; Rodrigo I Santos; Michelle Meyer; Mathieu Iampietro; Richard A Koup; Alexander Bukreyev
Journal:  PLoS Pathog       Date:  2016-12-08       Impact factor: 6.823

View more
  4 in total

1.  Virus-like insertions with sequence signatures similar to those of endogenous nonretroviral RNA viruses in the human genome.

Authors:  Shohei Kojima; Kohei Yoshikawa; Jumpei Ito; So Nakagawa; Nicholas F Parrish; Masayuki Horie; Shuichi Kawano; Keizo Tomonaga
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-02       Impact factor: 11.205

2.  Impact of Měnglà Virus Proteins on Human and Bat Innate Immune Pathways.

Authors:  Caroline G Williams; Joyce Sweeney Gibbons; Timothy R Keiffer; Priya Luthra; Megan R Edwards; Christopher F Basler
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

3.  Relevance of Ebola virus VP35 homo-dimerization on the type I interferon cascade inhibition.

Authors:  Francesco Di Palma; Gian Luca Daino; Venkata Krishnan Ramaswamy; Angela Corona; Aldo Frau; Elisa Fanunza; Attilio V Vargiu; Enzo Tramontano; Paolo Ruggerone
Journal:  Antivir Chem Chemother       Date:  2019 Jan-Dec

4.  Metagenomic Snapshots of Viral Components in Guinean Bats.

Authors:  Roberto J Hermida Lorenzo; Dániel Cadar; Fara Raymond Koundouno; Javier Juste; Alexandra Bialonski; Heike Baum; Juan Luis García-Mudarra; Henry Hakamaki; András Bencsik; Emily V Nelson; Miles W Carroll; N'Faly Magassouba; Stephan Günther; Jonas Schmidt-Chanasit; César Muñoz Fontela; Beatriz Escudero-Pérez
Journal:  Microorganisms       Date:  2021-03-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.